SUMMARY Minor and major deficiencies of enzymes affecting galactose metabolism may be associated with cataracts of early onset. Results are presented for 10 such families with minor enzymatic disorders. Expression of the major disorders probably involves galactitol accumulation and osmotic lens damage but this mechanism is not obviously associated with minor disorders. The observed incidence of minor incomplete enzymatic disorders of galactose metabolism in families with an incidence of cataracts of early onset may be at least partly incidental.
Major restriction of the normal pathways of galactose metabolism is associated with a high risk of cataract, as in homozygous deficiency of galactokinase or galactose-1-phosphate uridyl transferase, disorders involving transferase deficiency arising through low-activity variant forms, and these defects in various combinations. Heterozygous and lesser deficiencies, particularly of galactokinase, occur in families with an incidence of presenile cataracts,'-3 and minor deficiencies have also been found in mothers of enzymatically normal children with congenital cataracts, suggesting indirect influences during pregnancy. 4 Disorders of galactose metabolism may therefore have a more pervasive influence on the risk of cataract than is suggested by the incidence of the rare major disorders, and expression may be controlled by early recognition and dietary change. For the major disorders there is strong although partly indirect evidence that cataract arises through increased availability of galactose, with galactitol accumulation and osmotically-induced damage within the lens,5 6 and the risk of cataract also broadly associates with the extent of galactose intolerance.7 If the partial disorders are in similar direct relationship to the risk of cataract it may be possible to identify factors contributing to the wide variation of effect seen, and to identify individuals particularly at risk.
We have investigated the activity of galactose enzymes, and in some cases oral galactose tolerance, in families with an incidence of early onset and probably congenital bilateral cataracts. As with previous studies, abnormalities were 
Combined enzyme deficiencies
Deficiencies of erythrocyte galactokinase and galactose-l-phosphate uridyl transferase were identified in families 9 and 10. The mother in family 9 showed a confirmed minor deficiency of galactokinase and subnormal transferase activity as determined by a qualitative procedure: an abnormal, presumably Duarte variant enzyme pattern, was demonstratedl4 (Figure) .
Family 10 is of special interest and is reported in detail elsewhere.7 The child presented at age 7; years with impaired visual acuity then found to be associated with cataracts. Galactosuria was detected on routine screening. Further investigation during a period of 3 years showed that the child had partial deficiencies of both galactose enzymes, the levels of activity recorded fluctuating in parallel with changes in galactose tolerance. The parents did not have a defined monogenic disorder and the child was not a double heterozygote for galactokinase and galactose-1-phosphate uridyl transferase deficiency as was first thought. The minor deficiency of galactokinase observed in the father and high-to-normal galactose tolerance result for the child's maternal half-brother may indicate polygenic or other shared effects. Acquired influences including prematurity may also apply: liver function in the child was normal when assessed at age 9 years. Association with galactose tolerance. In the families cited, oral galactose tolerance was recorded for 2 heterozygotes for galactokinase deficiency without cataracts-in families 1 and 3: a mother and child with reduced galactokinase activity in family 8, the child also having cataracts, and for a further mother with minor reduction in activity of galactokinase and galactose-1-phosphate uridyl transferase in family 9 . Normal results were obtained in all cases. Two further children in families 1 and 9 with normal galactokinase activity and cataracts were also assessed, in addition to the child in family 8 with reduced galactokinase activity: of this group the child in family 1 showed borderline intolerance not related to any defined enzyme deficiency. The child in family 10 with double partial enzyme deficiencies showed major intolerance as described above. Relationship with pregnancy. Identification of partial maternal galactokinase deficiencies in families 2, 3, 4, 5, and 6 led to a recommendation to restrict lactose intake from, or preferably before, the start of any subsequent pregnancy. This restriction was associated with the birth of children without cataracts in families 2 and 6: compliance in family 4 was not achieved until at least the 5th week of pregnancy and a child with cataracts was born. Maternal restriction continues in families 3 and 5, pregnancy not yet being confirmed.
Galactosuria. This was found at presentation of the child in family 10 with double partial enzyme deficiencies, and of the 32-year-old woman with a history of cataracts of recent onset (family 11). Galactosuria was not found again in this second patient and activity of galactokinase and galactose-1-phosphate uridyl transferase, oral galactose tolerance, and liver function were normal: the family was not therefore investigated further.
Discussion
In common with previous authorsl-4 we 
